Biotage AB (publ) (STO:BIOT)

Market Cap	11.43B
Revenue (ttm)	1.96B
Net Income (ttm)	255.00M
Shares Out	80.05M
EPS (ttm)	3.18
PE Ratio	44.92
Forward PE	59.94
Dividend	1.65 (1.15%)
Ex-Dividend Date	Apr 25, 2025

Volume	57,956
Average Volume	167,315
Open	142.10
Previous Close	143.00
Day's Range	142.10 - 143.40
52-Week Range	81.60 - 202.20
Beta	0.85
RSI	63.12
Earnings Date	Aug 6, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal and supported scavengers and reagents, as well as accessories and spare parts...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 680
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOT

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.